BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10891666)

  • 21. Pseudomonas aeruginosa ecthyma gangrenosum and facial cellulitis complicating carbimazole-induced agranulocytosis.
    del Giudice P; Cua E; Bernard E; Chichmanian RM; Oregionni O; Brucker F; Dellamonica P
    Arch Dermatol; 2006 Dec; 142(12):1663-4. PubMed ID: 17179011
    [No Abstract]   [Full Text] [Related]  

  • 22. Antithyroid drug-induced aplastic anemia.
    Thomas D; Moisidis A; Tsiakalos A; Alexandraki K; Syriou V; Kaltsas G
    Thyroid; 2008 Oct; 18(10):1043-8. PubMed ID: 18816182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy.
    Sabri O; Zimny M; Schreckenberger M; Reinartz P; Ostwald E; Buell U
    Thyroid; 1999 Dec; 9(12):1181-8. PubMed ID: 10646656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatality complicating agranulocytosis in the setting of carbimazole therapy.
    Lynch MJ; Woodford NW
    Forensic Sci Med Pathol; 2008; 4(4):246-9. PubMed ID: 19291446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
    Wall JR; Fang SL; Kuroki T; Ingbar SH; Braverman LE
    J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyrotropin receptor antibodies and a genetic hint in antithyroid drug-induced adverse drug reactions.
    Chang LC; Chang CC; Chen PL; Wang SH; Chen YH; Tsai YH; Shih SR; Chiu WY; Fann CS; Yang WS; Chang TC
    Expert Opin Drug Saf; 2018 Aug; 17(8):775-784. PubMed ID: 30067105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experience with carbimazole in the treatment of the hyperthyroidism of Graves' disease in Nigerian patients.
    Modebe O
    Afr J Med Med Sci; 1995 Dec; 24(4):347-51. PubMed ID: 8886149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbimazole-induced pancytopaenia.
    Psomadakis C; Creamer A; Baynes C
    Br J Hosp Med (Lond); 2016 Apr; 77(4):248-9. PubMed ID: 27071434
    [No Abstract]   [Full Text] [Related]  

  • 29. Agranulocytosis associated with anti-thyroid drug in patients with Graves' thyrotoxicosis--report of 11 cases.
    Li KL; Huang HS; Wang PW; Lin JD; Juang JH; Liu RT; Huang BY; Huang MJ
    Changgeng Yi Xue Za Zhi; 1991 Sep; 14(3):168-73. PubMed ID: 1718579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Polyarthritis and synthetic antithyroid agents].
    Ansart S; Le Gal G; Pennec YL
    Rev Med Interne; 2000 Aug; 21(8):710. PubMed ID: 10989501
    [No Abstract]   [Full Text] [Related]  

  • 31. [A serious adverse effect: sepsis due to carbimazole].
    Guardiola PD; Tenreiro AP
    Endocrinol Nutr; 2009; 56(7):378-80. PubMed ID: 19883898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of Graves' disease--antithyroid drug therapy].
    Onaya T
    Nihon Rinsho; 1999 Aug; 57(8):1846-50. PubMed ID: 10483263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppression of Graves' hyperthyroidism--still an elusive goal.
    Wiersinga WM
    N Engl J Med; 1996 Jan; 334(4):265-6. PubMed ID: 8532007
    [No Abstract]   [Full Text] [Related]  

  • 34. Birth defects observed with maternal carbimazole treatment: Six cases reported to Nice's Pharmacovigilance Center.
    Koenig D; Spreux A; Hiéronimus S; Chichmanian RM; Bastiani F; Fénichel P; Brucker-Davis F
    Ann Endocrinol (Paris); 2010 Dec; 71(6):535-42. PubMed ID: 20934171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbimazole embryopathy.
    El Guendouz F; Hammoune N; Hommadi A; Zerhouni H; Baizri H
    Ann Endocrinol (Paris); 2017 Oct; 78(5):478-480. PubMed ID: 28870708
    [No Abstract]   [Full Text] [Related]  

  • 36. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease.
    Poomthavorn P; Mahachoklertwattana P; Tapaneya-Olarn W; Chuansumrit A; Chunharas A
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1295-301. PubMed ID: 12549809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbimazole treatment in smokers vs nonsmokers with Graves disease.
    Shin JI; Lee JS
    JAMA; 2009 May; 301(19):1988-9; author reply 1989. PubMed ID: 19454634
    [No Abstract]   [Full Text] [Related]  

  • 38. Which antithyroid drug regimen in paediatric Graves' disease?
    Schenk D; Donaldson M; Cheetham T
    Clin Endocrinol (Oxf); 2012 Dec; 77(6):806-7. PubMed ID: 22816522
    [No Abstract]   [Full Text] [Related]  

  • 39. Antithyroid drug induced a granulocytosis: what still we need to learn?
    Chaudhry LA; Mauzen KF; Ba-Essa E; Robert AA
    Pan Afr Med J; 2016; 23():27. PubMed ID: 27200132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of prior carbimazole on the outcome of radioiodine therapy in pediatric and adolescent Graves' disease.
    Ballal S; Soundararajan R; Singh H; Garg A; Chopra S; Bal C
    Nucl Med Commun; 2015 Jun; 36(6):566-72. PubMed ID: 25757198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.